The Role of Brain Interleukin-1 in Stress-enhanced Fear Learning
Overview
Affiliations
Posttraumatic stress disorder (PTSD) has been shown to be associated with pro-inflammatory markers, including elevated plasma levels of interleukin-1β (IL-1β). However, the precise role of neuroinflammation and central immune signaling on the development of this debilitating psychological disorder is not known. Here, we used stress-enhanced fear learning (SEFL), an animal model of the disorder, to examine the role of central IL-1β in PTSD. The results show that the severe stressor in SEFL induces a time-dependent increase in IL-1β immunoreactivity and mRNA expression within the dentate gyrus of the dorsal hippocampus (DH). There was no increase in IL-1β in the basolateral amygdala or the perirhinal cortex. Moreover, blocking the action of IL-1β following the severe stressor with IL-1 receptor antagonist (10 μg, intracerebroventricular (i.c.v.), 24 and 48 h after the stressor) prevented the development of SEFL. To provide further support for the role of IL-1β in the development of SEFL, we show that systemic morphine, a treatment which is known to reduce both PTSD and SEFL, also reduces IL-1β expression in the DH induced by the severe stressor. These studies provide the first evidence that IL-1 is involved SEFL and suggest that IL-1 signaling in the brain may have a critical role in the development of PTSD.
Knox D, Parikh V Neurosci Biobehav Rev. 2024; 159:105569.
PMID: 38309497 PMC: 10948307. DOI: 10.1016/j.neubiorev.2024.105569.
Lushchak O, Orru M, Strilbytska O, Berezovskyi V, Cherkas A, Storey K EXCLI J. 2023; 22:928-945.
PMID: 38023568 PMC: 10630527. DOI: 10.17179/excli2023-6391.
Post-traumatic Stress Disorder: Focus on Neuroinflammation.
Li J, Tong L, Schock B, Ji L Mol Neurobiol. 2023; 60(7):3963-3978.
PMID: 37004607 DOI: 10.1007/s12035-023-03320-z.
Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels.
Pang L, Li W, Yao S, Jing Y, Yin X, Cheng H Cancer Med. 2023; 12(10):11806-11815.
PMID: 36965094 PMC: 10242363. DOI: 10.1002/cam4.5847.
Parekh S, Adams L, Barkell G, Lysle D Psychopharmacology (Berl). 2023; 240(2):347-359.
PMID: 36633660 PMC: 9879843. DOI: 10.1007/s00213-023-06310-0.